PCI Pharma Services (PCI), a leading global contract development and manufacturing organization (CDMO), announced plans for a new 200,000-square-foot facility in Rockford, Illinois to enhance the organization’s capacity in injectable drug-device combination product assembly of both biologics and small molecules. Build…
Attibele in south Bengaluru will soon be a destination for innovation with city’s first organised life sciences cluster. Bengaluru Lifesciences Research (BLR) District, planned as a 52-acre campus with a total development of 2.5 million square feet, is poised to be an integrated, self-sustained cluster with state-of-t…
TFS HealthScience, a global contract research organization, announced its international expansion into Israel to enhance its offerings and geographic reach to support growing customer demand. The development includes a formalized agreement with the former external partner of TFS HealthScience in the Middle East, GCP C…
Ahmedabad-based Cadila Pharmaceuticals has signed a Memorandum of Understanding (MoU) with the government of Gujarat to invest Rs 1,000 crore in different existing projects. The MoU was signed in Gandhinagar between Industries Commissioner Rahul Gupta on behalf of the government of Gujarat and Cadila Pharmaceuticals …
Takeda Pharmaceutical will invest approximately 100 billion yen (¥) to build a new manufacturing facility for plasma-derived therapies (PDTs) in Osaka, Japan. The new state-of-the-art facility will be the largest of its kind in the country and is expected to be operational by around 2030. The new site increases the c…
The Federation of Indian Chambers of Commerce and Industry (FICCI) in partnership with Randstad India, one of the leading organisations in the HR services industry, has launched their exclusive survey on startup hiring trends. Over 300 startups participated in the survey. Despite the current trend of layoffs among la…
CND Life Sciences, a medical technology company pioneering the development of reliable skin-based tests to help clinicians diagnose neurodegenerative disorders like Parkinson’s disease and dementia with Lewy bodies, today announced the grand opening of its global headquarters in Scottsdale, Arizona. Occupying adjacent…
Evonik has officially begun construction of its $220 million global-scale production facility for pharmaceutical specialty lipids in Lafayette, Indiana, in the United States. The new facility is expected to secure the industry’s access to critical excipients needed for mRNA vaccines and other nucleic acid therapies. T…
Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and the Government of the Republic of Kenya have finalized an agreement to establish an mRNA manufacturing facility in the Republic of Kenya. This will be the Company’s first mRNA manufacturing facility in Africa. In part…
Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, announced that their stability storage business, Q1 Scientific, has opened a new 20,000 sq ft cGMP facility in Belgium, expanding its c…
Page 57 of 58